Universitätsmedizin Berlin Charité

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 Fusions/Rearrangements	Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, intrahepatic cholangiocarcinoma, neoplasm	Active, not recruiting	Phase 2	2025-12-05		NCT05174650
Sporadic Degenerative Ataxia With Adult Onset: Natural History Study	Late Onset Sporadic Cerebellar Ataxia	Recruiting	Not stated	2017-06-29		NCT02701036

Clinical trials